TSS
BEAM icon

Two Sigma Securities’s Beam Therapeutics BEAM Stock Holding History

Two Sigma Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Buy
+10,230
New +$284K 0.03% 927

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Two Sigma Securities's BEAM Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 10,230 shares worth $244K. The stake represents 0.03% of the portfolio and ranks #927 among its holdings.

251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Two Sigma Securities held 10,230 shares of Beam Therapeutics worth $244K as of Q1 2026.
  • Beam Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Beam Therapeutics made up 0.03% of Two Sigma Securities's portfolio in Q1 2026, its #927 holding.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.